Receptor activator of nuclear factor kappa B (RANK) as a determinant of peri-implantitis;Receptor aktivatora nuklearnog faktora kapa b kao cinilac periimplantitisa

Vojnosanitetski Pregled

Volumn 70, Issue 4, 2013, Pages 346-351

  Rakic, Mia ^a   Nikolic Jakoba, Nataša ^a   Struillou, Xavier ^b   Petkovic Curcin, Aleksandra ^c   Stamatović, Novak ^c,d   Matić, Smiljka ^c,d   Jankovic, Saša ^a   Aleksic, Zoran ^a   Vasilić, Djurdja ^a   Lekovic, Vojislav ^a   Vojvodic, Danilo ^c,d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITÉ DE NANTES   (France)

^c UNIVERSITY OF DEFENCE   (Serbia)

^d Serbia   (Serbia)

Author keywords

Dental implantation; Endosseus; Periodontitis; Receptor activator of nuclear factor kappa b; Sensitivity and specificity

Indexed keywords

RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIIMPLANTITIS; PERIODONTITIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TOOTH IMPLANT;

ADULT; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MIDDLE AGED; PERI-IMPLANTITIS; PERIODONTAL POCKET; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; YOUNG ADULT;

EID: 84875778130     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1304346R     Document Type: Article

References (38)

1. Mombelli A, Lang NP. The diagnosis and treatment of peri-implantitis. Periodontol 2000 1998; 17: 63-76.
2. Tonetti M. Risk factors for osseodisintegration. Periodontol 2000 1998; 17: 55-62.
3. Heitz-Mayfield L, Lang N. Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol 2000. 2010; 53: 167-181.
4. Ong CT, Ivanovski S, Needleman IG, Retzepi M, Moles DR, Tonetti MS, et al. Systematic review of implant outcomes in treated periodontitis subjects. J Clin Periodontol 2008; 35(5): 438-462.
5. Zambon JJ, Umemoto T, De Nardin E, Nakazawa F, Christersson LA, Genco RJ. Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv Dent Res 1988; 2(2): 269-274.
6. Teng YT. Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin li-gand (or RANK-L)- mediated alveolar bone destruction in vivo. Infect Immun 2002; 70(9): 5269-5273.
7. de Mendonça AC, Santos VR, César-Neto JB, Duarte PM. Tumor necrosis factor-alpha levels after surgical anti-infective mechanical therapy for peri-implantitis: a 12-month follow-up. J Periodontol 2009; 80(4): 693-699.
8. Petkovic A, Matic S, Stamatovic N, Vojvodic D, Todorovic T, Lazic Z, et al. Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg 2010; 39(5): 478-485.
9. Crotti T, Smith M, Hirsch R, Soukoulis S, Weedon H, Capone M, et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003; 38(4): 380-387.
10. Nagasawa T, Kiji M, Yashiro R, Hormdee D, Lu H, Kunze M, et al. Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000 2007; 43: 65-84.
11. Dutzan N, Gamonal J, Silva A, Sanz M, Vernal R. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis. J Clin Periodontol. 2009; 36(5): 396-403.
12. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001; 142(12): 5050-5055.
13. Kwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004; 15(1): 49-60.
14. Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 2001; 276(23): 20659-20672.
15. Soedarsono N, Rabello D, Kamei H, Fuma D, Ishihara Y, Suzuki M, et al. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis. J Periodontal Res 2006; 41(5): 397-404.
16. Buduneli N, Buduneli E, Kütükçüler N Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment. J Periodontol 2009; 80(8): 1274-1280.
17. Cochran D. Inflammation and bone loss in periodontal disease. J Periodontol 2008; 79 (Suppl 8): 1569-1576.
18. Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004; 15(6): 457-475.
19. Koide M, Kinugawa S, Takahashi N, Udagawa N Osteoclastic bone resorption induced by innate immune responses. Periodontol 2000 2010; 54(1): 235-246.
20. Wara-aswapati N, Surarit R, Chayasadom A, Boch JA, Pitiphat W. RANKL upregulation associated with periodontitis and Porphy-romonas gingivalis. J Periodontol 2007; 78(9): 1062-1069.
21. Taubman MA, Valverde P, Han X, Kawai T Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005; 76(Suppl 11): 2033-2041.
22. Kaklamanos E, Tsalikis L. A review on peri-implant crevicular fluid assays potential in monitoring and predicting peri-implant tissue responses. J Int Acad Periodontol 2002; 4(2): 49-59.
23. Sakellari D, Menti S, Konstantinidis A. Free soluble receptor activator of nuclear factor-kb ligand in gingival crevicular fluid correlates with distinct pathogens in periodontitis patients. J Clin Periodontol 2008; 35(11): 938-943.
24. Duarte P, de Mendonça A, Máximo M, Santos V, Bastos M, Nociti Júnior F. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res 2009; 20(5): 514-520.
25. Armitage GC Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4(1): 1-6.
26. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975; 25(4): 229-235.
27. Ataoglu H, Alptekin NO, Haliloglu S, Gursel M, Ataoglu T, Serpek B, et al. Interleukin-1 beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res 2002; 13(5): 470-476.
28. Nowzari H, Phamduong S, Botero JE, Villacres MC, Rich SK The Profile of Inflammatory Cytokines in Gingival Crevicular Fluid around Healthy Osseointegrated Implants. Clin Implant Dent Relat Res 2010 Jul 17 [Epub aheadof print]
29. Kanazawa K, Kudo A. Self-Assembled RANK Induces Osteoclastogenesis Ligand-Independently. J Bone Miner Res 2005; 20(11): 2053-2060.
30. Otero J, Dai S, Alhawagri M, Darwech I, Abu-Amer Y. IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis. J Bone Miner Res 2010; 25(6): 1282-1294.
31. Máximo MB, de Mendonça AC, Renata Santos V, Figueiredo LC, Feres M, Duarte PM. Short-term clinical and microbiological evaluations of peri-implant diseases before and after mechanical anti-infective therapies. Clin Oral Implants Res 2009; 20(1): 99-108.
32. Mörmann M, Thederan M, Nackchbandi I, Giese T, Wagner C, Hänsch GM. Lipopolysaccharides (LPS) induce the differentiation of human monocytes to osteoclasts in a tumour necrosis factor (TNF) alpha-dependent manner: a link between infection and pathological bone resorption. Mol Immunol 2008; 45(12): 3330-3337.
33. Tipton DA, Seshul BA, Dabbous MKH. Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. J Periodontal Res 2011; 46(1): 39-47.
34. Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007; 34(5): 370-376.
35. Nichols TC, Fischer TH, Deliargyris EN, Baldwin AS Jr. Role of nuclear factor-kappa B (NF-kappa B) in inflammation, periodontitis, and atherogenesis. Ann Periodontol 2001; 6(1): 20-29.
36. Baldwin AS Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001; 107(1): 3-6.
37. Choi BK Moon SY, Cha JH, Kim KW, Yoo YJ. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J Periodontol 2005; 76(5): 813-820.
38. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 2005; 32(4): 369-374.